Insider Selling: Globe Life (NYSE:GL) CEO Sells 12,500 Shares of Stock

Globe Life Inc. (NYSE:GL) CEO Frank Svoboda sold 12,500 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the completion of the sale, the chief executive officer owned 35,868 shares in the company, valued at $5,192,969.04. This represents a 25.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Globe Life Stock Down 1.5%

NYSE:GL traded down $2.13 during midday trading on Wednesday, reaching $143.79. 411,628 shares of the stock traded hands, compared to its average volume of 522,295. The stock has a market capitalization of $11.45 billion, a PE ratio of 10.21 and a beta of 0.47. Globe Life Inc. has a 12-month low of $109.38 and a 12-month high of $152.71. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07. The business has a 50-day moving average of $141.06 and a two-hundred day moving average of $138.48.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The business’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period in the previous year, the company posted $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Institutional Trading of Globe Life

A number of hedge funds have recently modified their holdings of GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Globe Life by 6.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after acquiring an additional 607 shares during the period. NewEdge Advisors LLC lifted its stake in shares of Globe Life by 368.1% in the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after purchasing an additional 5,352 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Globe Life by 11.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after purchasing an additional 58,163 shares during the period. Empowered Funds LLC purchased a new stake in Globe Life during the first quarter worth $428,000. Finally, Focus Partners Wealth grew its position in Globe Life by 8.3% during the first quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after buying an additional 656 shares during the period. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Wells Fargo & Company decreased their price target on Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Truist Financial upped their target price on Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research report on Friday, February 6th. JPMorgan Chase & Co. raised their target price on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, Piper Sandler reiterated an “overweight” rating and set a $167.00 price target on shares of Globe Life in a research note on Friday, November 21st. Eight analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $171.22.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.